ArticleBMC biotechnology2011

Engineering an L-cell line that expresses insulin under the control of the glucagon-like peptide-1 promoter for diabetes treatment.

Mina Rasouli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.